Articles

As a nine-year project to build vaccine development capacity worldwide comes to an end, PATH and partners reflect on how far we’ve come.

Improving vaccine coverage rates and vaccine acceptability in Serbia are critical issues. Locally made vaccines might be a part of the solution.

Dr. Le Van Be, director of the Institute of Vaccines and Medical Biologicals, believes in the power of vaccines. And he is committed to seeing locally made influenza vaccine become a reality.

An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 20-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached more than 300 million children—a turning point in the battle to protect people from this dreaded disease.